Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-3102024-01-01truefalsefalseThe principal activity of the company was occupational health services and wellbeing for the workplace. On 31 December 2023, the trade and assets of the company were transferred to its parent company, People Asset Management Ltd. Since the transfer, the company has ceased to trade.7true 04882890 2024-01-01 2024-12-31 04882890 2022-09-01 2023-12-31 04882890 2024-12-31 04882890 2023-12-31 04882890 c:Director1 2024-01-01 2024-12-31 04882890 d:CurrentFinancialInstruments 2024-12-31 04882890 d:CurrentFinancialInstruments 2023-12-31 04882890 d:ShareCapital 2024-12-31 04882890 d:ShareCapital 2023-12-31 04882890 d:RetainedEarningsAccumulatedLosses 2024-12-31 04882890 d:RetainedEarningsAccumulatedLosses 2023-12-31 04882890 c:EntityHasNeverTraded 2024-01-01 2024-12-31 04882890 c:FRS102 2024-01-01 2024-12-31 04882890 c:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 04882890 c:FullAccounts 2024-01-01 2024-12-31 04882890 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04882890 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 04882890









MEDPROTECT LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
MEDPROTECT LIMITED
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF MEDPROTECT LIMITED
FOR THE YEAR ENDED 31 DECEMBER 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Medprotect Limited for the year ended 31 December 2024 which comprise  the Statement of Financial Position and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the Board of Directors of Medprotect Limited, as a body, in accordance with the terms of our engagement letter dated 9 January 2025Our work has been undertaken solely to prepare for your approval the financial statements of Medprotect Limited and state those matters that we have agreed to state to the Board of Directors of Medprotect Limited, as a body, in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Medprotect Limited and its Board of Directors, as a body, for our work or for this report. 

It is your duty to ensure that Medprotect Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and result of Medprotect Limited. You consider that Medprotect Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Medprotect Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



WR Partners
 
Chartered Accountants
  
Gadbrook Way
Gadbrook Park
Northwich
Cheshire
CW9 7RA
26 September 2025
Page 1

 
MEDPROTECT LIMITED
REGISTERED NUMBER: 04882890

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
224,907
224,907

  
224,907
224,907

Total assets less current liabilities
  
 
 
224,907
 
 
224,907

  

Net assets
  
224,907
224,907


Capital and reserves
  

Called up share capital 
  
2
2

Profit and loss account
  
224,905
224,905

  
224,907
224,907


Page 2

 
MEDPROTECT LIMITED
REGISTERED NUMBER: 04882890
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024

For the year ended 31 December 2024 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 September 2025.




................................................
A Bones
Director

The notes on pages 4 to 5 form part of these financial statements.

Page 3

 
MEDPROTECT LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Medprotect Limited is a private company limited by shares incorporated in England and Wales. The registered office is 9 Lakeside Drive (Also known as 820 Mandarin court), Centre Park, Warrington, WA1 1GG.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

 
2.2

Going concern

On 22 December 2023, the company hived up its trade and assets to its parent company, People Asset Management Ltd and no longer trades. At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to meet its financial commitments for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
MEDPROTECT LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.



3.


Employees

The average monthly number of employees, including directors, during the year was 0 (2023 - 7).


4.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
224,907
224,907

224,907
224,907


Page 5